This new, patented nutraceutical supports:
- Enhanced cognitive function*
- Heightened focus, concentration, and energy*
- Improved mental alertness and clarity of thought*
Documented Safety, Tolerability and Efficacy in Human Subjects
A recent single-blind, dose titration, outpatient study evaluated the efficacy of Cogniben™ in 10 adults (18 to 55 years) with symptoms of cognitive impairment. Subjects were titrated from half tablet of Cogniben™ daily, up to the maximal allowed dose of two tablets per day by the end of the 2nd week. This dose was maintained for an additional 5 weeks. Subjects’ symptoms, well-being, and improvements were assessed via questionnaires at baseline and subsequent visits. The primary efficacy endpoint was the average change from baseline to endpoint in total average symptom score.
A synergistic blend of ingredients:
Ginkgo biloba – a botanical with proven cognitive benefits; supports improved blood flow to the brain and contributes to optimal cognitive function and concentration.
Phenylethylamine (PEA) – known to modulate dopaminergic, serotonergic, and adrenergic activities, optimizing psychological energy/focus and enhanced concentration.
Caffeine – in an amount equal to approximately one-half cup of coffee, caffeine modulates the adenosine family of receptors in the brain. Caffeine’s actions may enhance brain activity and mental alertness.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.